• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用放射自显影术检测低水平组胺 H3 受体占有率。

Detection of low level histamine H3 receptor occupancy by autoradiography.

机构信息

World Wide Discovery Research, Cephalon, Inc., West Chester, PA 19380, USA.

出版信息

J Neurosci Methods. 2009 Dec 15;185(1):70-5. doi: 10.1016/j.jneumeth.2009.09.015. Epub 2009 Sep 16.

DOI:10.1016/j.jneumeth.2009.09.015
PMID:19765611
Abstract

Histamine H(3) receptor antagonists have been proposed as a novel approach to the treatment of cognitive, attentional, and sleep disorders. It is apparent that H(3) receptor antagonists produce in vivo effects in preclinical animal models of central diseases across a wide dose range. In order to characterize the relationship between efficacy in the preclinical models and H(3) receptor occupancy, a brain slice receptor autoradiography method was used. Brain slice receptor autoradiography requires less in vitro tissue processing, preserves brain structure, and provides anatomical localization of compound in the brain. Consistent with H(3) receptor distribution, in vitro autoradiography experiments demonstrated specific binding of [(3)H]NAMH (N-alpha-methylhistamine) in rat cortex, and other brain regions, but not in cerebellum. Ex vivo H(3)R brain slice autoradiography was able to detect H(3) receptor occupancy by reference antagonists at doses lower than previously found using a homogenate assay format. The method is relatively quick with image acquisition on a beta-imager and is capable of detecting receptor occupancy in different brain regions simultaneously. Furthermore, the increased sensitivity should be useful in providing dosing guidelines for H(3) antagonists in both preclinical and clinical settings.

摘要

组胺 H(3)受体拮抗剂被认为是治疗认知、注意力和睡眠障碍的一种新方法。显然,H(3)受体拮抗剂在中枢疾病的临床前动物模型中,在很宽的剂量范围内产生体内效应。为了描述临床前模型中的疗效与 H(3)受体占有率之间的关系,采用了脑切片受体放射自显影方法。脑切片受体放射自显影需要较少的体外组织处理,保留了脑结构,并提供了化合物在脑内的解剖定位。与 H(3)受体分布一致,体外放射自显影实验表明,[(3)H]NAMH(N-α-甲基组氨酸)在大鼠皮质和其他脑区特异性结合,但不在小脑结合。通过参考拮抗剂,在体外 H(3)R 脑切片放射自显影中,能够检测到比以前在匀浆测定中发现的更低剂量的 H(3)受体占有率。该方法相对较快,在β-成像仪上进行图像采集,并能够同时检测不同脑区的受体占有率。此外,增加的灵敏度应该有助于为 H(3)拮抗剂在临床前和临床环境中的给药提供指导。

相似文献

1
Detection of low level histamine H3 receptor occupancy by autoradiography.用放射自显影术检测低水平组胺 H3 受体占有率。
J Neurosci Methods. 2009 Dec 15;185(1):70-5. doi: 10.1016/j.jneumeth.2009.09.015. Epub 2009 Sep 16.
2
Correlation between ex vivo receptor occupancy and wake-promoting activity of selective H3 receptor antagonists.选择性H3受体拮抗剂的体外受体占有率与促觉醒活性之间的相关性。
J Pharmacol Exp Ther. 2008 Jun;325(3):902-9. doi: 10.1124/jpet.107.135343. Epub 2008 Feb 27.
3
Comparison of the binding distribution of agonist and antagonist ligands for histamine H3 receptors in pig brain by quantitative autoradiography.通过定量放射自显影术比较猪脑中组胺H3受体激动剂和拮抗剂配体的结合分布。
Eur J Pharmacol. 2007 Jun 14;564(1-3):75-9. doi: 10.1016/j.ejphar.2007.01.087. Epub 2007 Feb 14.
4
Synthesis and in vitro pharmacology of a series of new chiral histamine H3-receptor ligands: 2-(R and S)-Amino-3-(1H-imidazol-4(5)-yl)propyl ether derivatives.一系列新型手性组胺H3受体配体的合成及体外药理学研究:2-(R和S)-氨基-3-(1H-咪唑-4(5)-基)丙基醚衍生物
J Med Chem. 1999 Apr 8;42(7):1193-202. doi: 10.1021/jm980408v.
5
Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects.两种新型选择性非咪唑类组胺H3受体拮抗剂A-304121和A-317920:I. 体外药理作用
J Pharmacol Exp Ther. 2003 Jun;305(3):887-96. doi: 10.1124/jpet.102.047183. Epub 2003 Feb 20.
6
4-phenoxypiperidines: potent, conformationally restricted, non-imidazole histamine H3 antagonists.4-苯氧基哌啶类:强效、构象受限的非咪唑类组胺H3拮抗剂。
J Med Chem. 2005 Mar 24;48(6):2229-38. doi: 10.1021/jm049212n.
7
Search for novel leads for histamine H3-receptor antagonists: oxygen-containing derivatives.寻找组胺H3受体拮抗剂的新型先导化合物:含氧化合物。
Pharmazie. 1997 Jul;52(7):495-500.
8
Pharmacological characterization of GT-2016, a non-thiourea-containing histamine H3 receptor antagonist: in vitro and in vivo studies.GT-2016(一种不含硫脲的组胺H3受体拮抗剂)的药理学特性:体外和体内研究
J Pharmacol Exp Ther. 1995 Nov;275(2):598-604.
9
Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligands.一系列新型1H-4-取代咪唑基组胺H3受体配体的鉴定及药理学特性研究
J Pharmacol Exp Ther. 1999 May;289(2):1151-9.
10
[125I]iodoproxyfan, a new antagonist to label and visualize cerebral histamine H3 receptors.[125I]碘普罗番,一种用于标记和可视化脑内组胺H3受体的新型拮抗剂。
J Pharmacol Exp Ther. 1994 Oct;271(1):452-9.

引用本文的文献

1
Novel chalcone-based fluorescent human histamine h(3) receptor ligands as pharmacological tools.新型查尔酮类荧光人组氨酸 h(3)受体配体作为药理学工具。
Front Syst Neurosci. 2012 Mar 26;6:14. doi: 10.3389/fnsys.2012.00014. eCollection 2012.
2
Lipopolysaccharide induces H1 receptor expression and enhances histamine responsiveness in human coronary artery endothelial cells.脂多糖诱导人冠状动脉内皮细胞 H1 受体表达并增强其组胺反应性。
Immunology. 2011 Apr;132(4):578-88. doi: 10.1111/j.1365-2567.2010.03403.x. Epub 2011 Jan 24.